Huawei Ascend vs Nvidia: China AI Chip Market Share, November 2026
Huawei Ascend reportedly reached 28% of China's AI chip market as Nvidia's share fell to 34%, a shift underpinned by an accelerated hardware roadmap, open-source tooling from DeepSeek, and persistent U.S. export restrictions.
A market-share snapshot reported by multiple outlets in October and November 2026 crystallizes the ongoing realignment of China's AI accelerator landscape: Huawei's Ascend line reportedly accounts for 28% of the domestic AI chip market, while Nvidia's share has fallen to 34%. Neither figure has been independently audited, and Slicast treats them as directionally credible rather than definitive; that said, the consistency across distinct publications, combined with corroborating evidence on hardware deployments, software ecosystem investment, and institutional deal-making, makes the directional conclusion difficult to dispute. What the numbers represent is not a single quarterly swing but the visible outcome of a multi-year forced divergence: successive rounds of U.S. export controls have progressively constrained the availability of leading-edge Nvidia accelerators in China, while Huawei has built out the hardware, software, and system-integration stack needed to absorb displaced demand.
The software dimension has emerged as a structurally important accelerant. Through September and October 2026, DeepSeek and Huawei jointly published open-source tools targeting the Ascend ecosystem — including TileLang, an Ascend-native programming language, and compute and communication libraries for the Ascend 950 AI accelerator — explicitly positioned as alternatives to Nvidia's proprietary CUDA platform. DeepSeek subsequently fully open-sourced its inference framework, which supports both Nvidia GPUs and Huawei Ascend; reported single-cluster throughput stands at 155 trillion tokens per day, with per-card revenue cited at $38 per hour. For infrastructure operators and investors, this matters because accelerator ecosystems derive much of their stickiness from the software layer: developer tooling, optimized libraries, and framework integrations accumulate switching costs over time. The active investment by one of China's most prominent AI research organizations in Ascend-compatible tooling reduces development overhead for other operators and expands the workload base addressable by Huawei's chips.
On the hardware side, the product cadence at Huawei Connect 2026 in September was notable in its breadth. The company introduced the UnifiedBus computing architecture for SuperPods and large-scale clusters, upgraded its Stellar AI Fabric interconnect solution, and launched the OceanStor M900 context memory storage system for hyperscale AI inference. The Ascend 960PR's FP4 performance was reported to double initial expectations, and a Huawei executive reportedly confirmed the Ascend 960 accelerator has been pulled forward to a Q1 2027 commercial availability date — a meaningful schedule compression relative to the prior roadmap. The company's 15,488-chip Atlas cluster, using optical interconnects, is said to reach 120 EFLOPS, placing it squarely in the competitive range for large-scale training infrastructure. Taken together, these releases describe a full-stack infrastructure play — accelerator, interconnect, and storage — rather than a chip-only proposition. Separately, a Huawei executive was reported in September 2026 to have claimed that domestic AI chip sales had already surpassed Nvidia's in China; Slicast notes that claim has not been independently verified and distinguishes it from an audited market figure.
Two developments in October add a layer of intellectual property and geopolitical context. Huawei and Qualcomm signed a multi-year patent license agreement spanning 5G, compute, AI, and networking technologies; Qualcomm separately obtained a license to Huawei's LogicFolding chip design patents, described in reports as a distinct transaction. Financial terms were not disclosed. Multiple reports characterize the structure as reversing the historical royalty flow — with Huawei moving toward a net-recipient position. If accurate, it would signal a meaningful shift in Huawei's IP portfolio status, from net licensee of Western semiconductor IP to a licensor recognized by one of the industry's largest patent holders. Against that backdrop, memory supply remains the most visible near-term constraint. High-bandwidth memory sourced outside official channels has reportedly reached $4,000 per unit, and Huawei is said to be in discussions with SK Hynix and Samsung as potential supply partners. CXMT entered mass production of its fifth-generation DRAM in September 2026 — an incremental step — but HBM-class output from Chinese foundries at the volume and specification required for large cluster builds has not been confirmed.
The bull case for continued Ascend share gains rests on durable structural tailwinds: a large and growing domestic market with constrained top-end competition, an accelerating hardware roadmap, deepening software ecosystem alignment through DeepSeek, and emerging IP leverage demonstrated by the Qualcomm deal. The bear case is equally concrete: persistent domestic HBM supply gaps that could throttle cluster scaling, a global addressable market that remains largely inaccessible under current export control regimes, and the fact that Nvidia — with 34% share despite restrictions — retains a presence that cannot yet be assumed to be terminal. Huawei has also reportedly shelved its near-term global Ascend rollout because domestic demand already exceeds supply, which constrains revenue diversification. Three signals are worth monitoring: whether the Ascend 960 ships on its Q1 2027 schedule and at what production volumes; whether a credible domestic or licensed HBM supply pathway emerges before memory constraints become a hard ceiling on cluster deployment; and whether DeepSeek's open-source Ascend toolchain attracts meaningful adoption from developers outside mainland China — an outcome that would signal a qualitative expansion of Huawei's AI chip moat beyond its current regulatory shelter.